Physician profile
James Parramore
NPI 1760595508
$9,835.64
in general payments reported to CMS, 2019-2025
15 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $126 · 2021: $4,996 · 2022: $3,100 · 2023: $60.50 · 2024: $168 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,322.82 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $961.89 | 2019 | |
| Medtronic, INC. | $155.07 | 2021 | |
| Ethicon US, LLC | $68.96 | 2019-2023 | Linx Reflux Management System, Echelon Flex |
| Daiichi Sankyo INC. | $63.10 | 2024 | Enhertu |
| Davol INC. | $59.77 | 2022-2024 | Phasix Mesh |
| Smith+Nephew, INC. | $56.18 | 2019 | |
| Conmed Corporation | $50.09 | 2024 | Airseal |
| Teleflex LLC | $18.61 | 2019 | |
| Karl Storz Endoscopy-America | $17.50 | 2020 | |
| Mallinckrodt Hospital Products INC. | $17.22 | 2020 | |
| Kci USA, INC. | $13.17 | 2022 | |
| Braintree Laboratories, INC. | $11.60 | 2021 | |
| Tela Bio, INC. | $10.82 | 2019 | |
| Ets Wound Care LLC | $8.84 | 2025 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Parramore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.